|Bid||456.67 x 900|
|Ask||457.42 x 900|
|Day's Range||455.59 - 460.91|
|52 Week Range||292.17 - 473.79|
|PE Ratio (TTM)||69.61|
|Earnings Date||Jul 18, 2018 - Jul 23, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||478.67|
Higher adoption of Intuitive Surgical's (ISRG) robot-based da Vinci system and increasing procedure volumes are key catalysts at the moment.
This increased rate in commercial insurer coverage for Myriad Genetics' (MYGN) Prolaris comes close on the heels of the NCCN guidelines.
Zimmer Biomet (ZBH) receives FDA's approval for the new system, which is likely to augment the company's lumbar spacers portfolio.
Cardiovascular Systems (CSII) gains traction from a strong third-quarter fiscal 2018, witnessing a year-over-year revenue rise at both CAD and PAD businesses.
Medtronic (MDT) is poised to gain on strength in Diabetes business in Q4 on continued uptake of MiniMed 670G system in the United States along with enhanced sensor supply capacity.
ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference.
Varian Medical (VAR) opts to spread radiotherapy accessibility in Latin America through Brazil MOH, other international ventures of the company hold promise.
A rapidly changing healthcare environment in the United States, sluggish first quarter, declining margins and foreign exchange headwinds continue to hurt DENTSPLY SIRONA (XRAY).
Medtronic (MDT) focuses on boosting CSH segment. Notably, successful results from The Bifurcation Cohort study will help the company to achieve expanded FDA approval for the Resolute Onyx DES.
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NEW YORK, NY / ACCESSWIRE / May 16, 2018 / What makes a great investment among medical device companies? This takes great execution. Intuitive Surgical (ISRG) and ResMed (RMD) have both executed flawlessly, leaving their counterparts in the dust - early investors have made out tremendously well.
Mellanox Technologies, MGM Resorts International, BP, Texas Instruments and Intuitive Surgical highlighted as Zacks Bull and Bear of the Day
Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.
This morning the MZOR management reported earnings and they beat the top and bottom lines. Fundamentally, MZOR stock is not a cheap stock from the traditional price-to-earnings ratio perspective. Year-to-date Mazor Robotics stock was up 10% but lagging slightly behind Intuitive Surgical, Inc. (NASDAQ:ISRG), which was up 25%.